Today it was reported that the CFO of Proto Labs (NYSE: PRLB), John Way, exercised options to sell 3,912 PRLB shares at $62.90 a share, for a total transaction value of $570.3K.
In addition to John Way, 2 other PRLB executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Proto Labs’ latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $110 million and quarterly net profit of $18.31 million. In comparison, last year the company earned revenue of $82.04 million and had a net profit of $12.09 million. PRLB’s market cap is $4.01B and the company has a P/E ratio of 63.21. Currently, Proto Labs has an average volume of 65.81K.
In the last 30 days, insiders have sold $570.3K worth of PRLB shares and purchased $8,896 worth of PRLB shares. The insider sentiment on Proto Labs has been negative according to 37 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Proto Labs, Inc. engages in the digital manufacture of custom prototypes and production parts. It operates through the following geographical segments: United States, Europe, and Japan. It offers 3D printing, CNC machining, and injection molding services.
